Skip to main content
Premium Trial:

Request an Annual Quote

Prenosis Wins $749K BARDA Contract for Sepsis Prediction Software

NEW YORK – Prenosis said on Wednesday that it has been awarded a contract from the US Department of Health and Human Services' Biomedical Advanced Research and Development Authority.

The Chicago-based spinout from the University of Illinois at Urbana-Champaign declined to disclose the amount of the grant, but according to the database, the award is for $749,000.

Prenosis said it will use the funding to demonstrate the clinical value of its Sepsis ImmunoScore, an AI/machine learning-based software for predicting sepsis based on clinical parameters and protein biomarkers. ImmunoScore assesses patients' risks of progressing to sepsis after they have been admitted to the emergency department or hospital. Prenosis said the BARDA award will be used to implement a study at three hospitals to demonstrate its deployment in a live hospital environment, as well as to assess whether ImmunoScore can aid in clinical decisions and improve patient outcomes. 

In late November, the company won up to $4.3 million from the US Department of Defense to develop technology for the early detection of sepsis in warfighters at the point of care.